Scale and reach Harvard Drug Group is the second largest generics-focused distributor in the US with a broad customer base of over 7,000 retail customers, presenting a sizable sales opportunity to expand coverage and cross-sell generic and brand pharmaceuticals through existing and new manufacturers.

Strategic locations Multiple distribution facilities across Michigan, Indiana, and Alabama combined with regional sales offices in several states suggest opportunities to optimize logistics, reduce lead times, and upsell value-added services to nearby pharmacies and clinics.

Recall risk exposure Recent recalls involving Rugby Laboratories products and dronabinol labeling incidents highlight a need for robust quality assurance, regulatory compliance support, and alternative product sourcing to mitigate supply chain risk for customers.

Technology adoption Utilizes cloud and modern tech stack including AWS, Google Cloud, WordPress, and Dynatrace, which can be leveraged to implement enhanced order visibility, tracking, compliance analytics, and faster onboarding for new manufacturers and customers.

Partnership potential Under Cardinal Health ownership and with a substantial revenue base in the mid-market range, there is opportunity to position Harvard Drug Group as a preferred distributor for manufacturers seeking nationwide reach, scoped distribution agreements, and co-marketing initiatives.